Q4 2021 Sartorius AG Earnings Call Transcript
Good day, and welcome to the Sartorius and Sartorius Stedim Biotech Conference Call on the Preliminary Fiscal Year 2021 Results. Today's conference is being recorded.
At this time, I would like to turn the conference over to Dr. Joachim Kreuzburg, CEO. Please go ahead, sir.
Thank you very much, and welcome, everybody, to our conference call today on the preliminary numbers for fiscal year 2021 for both the Sartorius Group as well as for Sartorius Stedim Biotech. As always, I will run this call together with our CFO, Rainer Lehmann, who will walk you through the details of our financial results in a minute.
Before that, I would like to start off by talking a little bit about maybe the highlights and the most important results of last year. I think it's fair to say that 2021 has been an outstanding year for both divisions, very strong growth rates that we have achieved in both divisions, both top line as well as bottom line. We also were able to further
| Access to All Earning Calls and Stock Analysis | |
| 30-Year Financial on one screen | |
| All-in-one Stock Screener with unlimited filters | |
| Customizable Stock Dashboard | |
| Real Time Insider Trading Transactions | |
| 8,000+ Institutional investors’ 13F holdings | |
| Powerful Excel Add-in and Google sheets Add-on | |
| All data downloadable | |
| Quick customer support | |
| And much more... |
Trustpilot
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
